Novel associations between activating killer-cell immunoglobulin-like receptor genes and childhood leukemia

Blood

Volumn 118, Issue 5, 2011, Pages 1323-1328

  Almalte, Zaema ^a,b   Samarani, Suzanne ^a,b   Iannello, Alexandre ^a,b   Debbeche, Olfa ^a,b,c   Duval, Michel ^a,b,d   Infante Rivard, Claire ^c   Amre, Devendra K ^a,b   Sinnett, Daniel ^a,b,d   Ahmad, Ali ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Charles Bruno Cancer Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANADA; CANCER RISK; CASE CONTROL STUDY; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INFANT; INHERITANCE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD;

EID: 80051561450     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-10-313791     Document Type: Article

References (37)

1. Stiller CA. Epidemiology and genetics of childhood cancer. Oncogene. 2004;23(38):6429-6444. (Pubitemid 39265508)
2. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36(4):277-285.
3. Sinnett D, Krajinovic M, Labuda D. Genetic susceptibility to childhood acute lymphoblastic leukemia. Leuk Lymphoma. 2000;38(5-6):447-462. (Pubitemid 30614530)
4. Krajinovic M, Sinnett H, Richer C, Labuda D, Sinnett D. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer. 2002;97(2):230-236. (Pubitemid 34019960)
5. Healy J, Belanger H, Beaulieu P, Lariviere M, Labuda D, Sinnett D. Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia. Blood. 2007;109(2):683-692. (Pubitemid 46105970)
6. Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood. 2004;103(1):252-257. (Pubitemid 38029946)
7. Trevino LR, Yang W, French D, et al. Germline genomic variations associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9):1001-1005.
8. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9):1006-1010.
9. Han S, Lee K-M, Park SK, et al. Genome wide association study of childhood acute lymphoblastic leukemia in Korea. Leuk Res. 2010;34(10):1271- 1274.
10. Yawata M, Yawata N, Abi-Rached L, Parham P. Variation within the human killer cell immunoglobulin- like receptor (KIR) gene family. Crit Rev Immunol. 2002;22(5-6):463-482. (Pubitemid 36548955)
11. Parham P. Immunogenetics of killer cell immunoglobulin- like receptors. Mol Immunol. 2005;42(4):459-462. (Pubitemid 39655954)
12. Iannello A, Debbeche O, Samarani S, Ahmad A. Antiviral NK cell responses in HIV infection, I: NK cell receptor genes as determinants of resistance to HIV infection and progression to AIDS. J Leukoc Biol. 2008;84(1):1-26. (Pubitemid 351960277)
13. Zhang Y, Wang B, Ye S, et al. Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease. Leukemia Res. 2010;34(1):55-58.
14. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. (Pubitemid 34229476)
15. Verheyden S, Demanet C. NK cell receptors and their ligands in leukemia. Leukemia. 2008;22(2):249-257. (Pubitemid 351250528)
16. Maxwell LD, Williams F, Gilmore P, Meenagh A, Middleton D. Investigation of killer-cell immunoglobulin-like receptor gene diversity, II: KIR2DS4. Hum Immunol. 2004;65(6):613-621. (Pubitemid 38813412)
17. Giebel S, Nowak I, Krawczyk-Kulis M, Holowiecki H, Kyrcz-Krzemien Kursnierczyk P. Association of KIR2DS4 and its variant KIR1D with leukemia. Leukemia. 2008;22(11):2129-2130.
18. Martin MP, Gao X, Lee JH, et al. Epistatic interaction between KIR3DS1 and HLA-B delays progression to AIDS. Nat Genet. 2002;31(4):429-434. (Pubitemid 35154456)
19. Hiby SE, Walker JJ, O'Shaughnessy KM, et al. Combinations of maternal KIR and foetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004;200(8):957-965. (Pubitemid 39431121)
20. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. (Pubitemid 34229476)
21. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest. 2008;118(3):1017-1026. (Pubitemid 351364609)
22. Boulet S, Sharafi S, Simic N, et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS. 2008;22(5):595-599. (Pubitemid 351640592)
23. Kulkarni S, Martin MP, Carrington M. The Yin and Yang of HLA and KIR in human disease. Semin Immunol. 2008;20(20):343-352.
24. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood. 2002;100(6):1935-1947. (Pubitemid 35001221)
25. Amre DK, Mack DR, Morgan K, et al. Autophagy gene ATG16L1 but not IRGM is associated with Crohn's disease in Canadian children. Inflamm Bowel Dis. 2009;15(4):501-507.
26. Amre DK, Mack D, Israel D, et al. Association between genetic variants in the IL-23R gene and early-onset Crohn's disease: results from a casecontrol and family-based study among Canadian children. Am J Gastroenterol. 2008;103(3):615-620. (Pubitemid 351405996)
27. Amre DK, Mack DR, Morgan K, et al. Investigation of reported associations between the 20a13 and 21q22 loci and pediatric-onset Crohn's disease in Canadian children. Am J Gastroenterol. 2009;104(11):2824-2828.
28. Uhrberg M, Parham P, Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven genes. Immunogenetics. 2002;54(4):221-229. (Pubitemid 34824132)
29. Uhrberg M, Valiante NM, Shum BP et al. Human diversity in killer cell inhibitory receptor genes. Immunity. 1997;7(6):753-763. (Pubitemid 28064889)
30. Vilches C, Rajalingam R, Uhrberg M, Gardiner C, Young NT, Parham P. KIR2DL5, a novel killer-cell receptor with a D0-D1 configuration of Ig-like domains. J Immunol. 2000;164(11):5797-5804. (Pubitemid 30389823)
31. Yawata M, Yawata N, McQueen KL, et al. Predominance of group A haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics. 2002;54(8):543-550. (Pubitemid 35435512)
32. Zhi-ming L, Yu-lian J, Zhao-li F, et al. Polymorphisms of killer-cell immunoglobulin-like receptor gene: possible association with susceptibility to or clearance of hepatitis B virus infection in Chinese Han population. Croat Med J. 2007;48(6):800-806.
33. Gomez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens. 2002;59(3):184-193. (Pubitemid 34666561)
34. Verheyden S, Demanet C. Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions. Leukemia. 2006;20(8):1437-1438. (Pubitemid 44084059)
35. Verheyden S, Bernier M, Demanet C. Identification of natural killer cell receptor phenotypes associated with leukemia. Leukemia. 2004;18(12):2002-2007. (Pubitemid 40028427)
36. Katz G, Markel G, Mizrahi S, Arnon TI, Mandelboim O. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short-tail number 4. J Immunol. 2001;166:7260-7267. (Pubitemid 32525600)
37. Katz G, Gazit R, Arnon TI, et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol. 2004;173(3):1819-1825. (Pubitemid 38971615)